272 related articles for article (PubMed ID: 15891348)
1. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine.
De-Souza DA; Greene LJ
Crit Care Med; 2005 May; 33(5):1125-35. PubMed ID: 15891348
[TBL] [Abstract][Full Text] [Related]
2. Can glutamine turn off the motor that drives systemic inflammation?
Wischmeyer PE
Crit Care Med; 2005 May; 33(5):1175-8. PubMed ID: 15891373
[No Abstract] [Full Text] [Related]
3. Glutamine improves intestinal barrier function in experimental biliary obstruction.
White JS; Hoper M; Parks RW; Clements WD; Diamond T
Eur Surg Res; 2005; 37(6):342-7. PubMed ID: 16465058
[TBL] [Abstract][Full Text] [Related]
4. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study.
Conejero R; Bonet A; Grau T; Esteban A; Mesejo A; Montejo JC; López J; Acosta JA
Nutrition; 2002 Sep; 18(9):716-21. PubMed ID: 12297203
[TBL] [Abstract][Full Text] [Related]
5. Effects of glutamine on intestinal permeability and bacterial translocation in TPN-rats with endotoxemia.
Ding LA; Li JS
World J Gastroenterol; 2003 Jun; 9(6):1327-32. PubMed ID: 12800250
[TBL] [Abstract][Full Text] [Related]
6. Gut dysfunction in critically ill patients: a review of the literature.
Stechmiller JK; Treloar D; Allen N
Am J Crit Care; 1997 May; 6(3):204-9. PubMed ID: 9131199
[TBL] [Abstract][Full Text] [Related]
7. Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials.
Stehle P; Ellger B; Kojic D; Feuersenger A; Schneid C; Stover J; Scheiner D; Westphal M
Clin Nutr ESPEN; 2017 Feb; 17():75-85. PubMed ID: 28361751
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatitis and translocation--approaches for nutritional strategies].
Foitzik T
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():596-8. PubMed ID: 9931685
[TBL] [Abstract][Full Text] [Related]
9. Review article: bacterial translocation in the critically ill--evidence and methods of prevention.
Gatt M; Reddy BS; MacFie J
Aliment Pharmacol Ther; 2007 Apr; 25(7):741-57. PubMed ID: 17373913
[TBL] [Abstract][Full Text] [Related]
10. Glutamine stabilizes intestinal permeability and reduces pancreatic infection in acute experimental pancreatitis.
Foitzik T; Stufler M; Hotz HG; Klinnert J; Wagner J; Warshaw AL; Schulzke JD; Fromm M; Buhr HJ
J Gastrointest Surg; 1997; 1(1):40-6; discussion 46-7. PubMed ID: 9834329
[TBL] [Abstract][Full Text] [Related]
11. Does glutamine-enriched parenteral nutrition really affect intestinal morphology and gut permeability?
Hulsewé KW; van Acker BA; Hameeteman W; van der Hulst RR; Vainas T; Arends JW; van Kreel BK; von Meyenfeldt MF; Soeters PB
Clin Nutr; 2004 Oct; 23(5):1217-25. PubMed ID: 15380916
[TBL] [Abstract][Full Text] [Related]
12. Influence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients.
Velasco N; Hernandez G; Wainstein C; Castillo L; Maiz A; Lopez F; Guzman S; Bugedo G; Acosta AM; Bruhn A
Nutrition; 2001; 17(11-12):907-11. PubMed ID: 11744338
[TBL] [Abstract][Full Text] [Related]
13. [Practical aspects of early enteral feeding].
Bastian L; Weimann A
Anaesthesiol Reanim; 1999; 24(4):95-100. PubMed ID: 10528415
[TBL] [Abstract][Full Text] [Related]
14. Artificial nutrition and intestinal mucosal barrier functionality.
Anastasilakis CD; Ioannidis O; Gkiomisi AI; Botsios D
Digestion; 2013; 88(3):193-208. PubMed ID: 24247113
[TBL] [Abstract][Full Text] [Related]
15. Dietary glutamine prevents the loss of intestinal barrier function and attenuates the increase in core body temperature induced by acute heat exposure.
Soares AD; Costa KA; Wanner SP; Santos RG; Fernandes SO; Martins FS; Nicoli JR; Coimbra CC; Cardoso VN
Br J Nutr; 2014 Nov; 112(10):1601-10. PubMed ID: 25322775
[TBL] [Abstract][Full Text] [Related]
16. [The intestine as an immunological organ].
Stallmach A; Zeitz M
Wien Klin Wochenschr; 1998 Feb; 110(3):72-8. PubMed ID: 9553201
[TBL] [Abstract][Full Text] [Related]
17. Exogenous glutamine--compensating a shortage?
Tjader I; Berg A; Wernerman J
Crit Care Med; 2007 Sep; 35(9 Suppl):S553-6. PubMed ID: 17713408
[TBL] [Abstract][Full Text] [Related]
18. [Intestinal mucosal barrier dysfunction after abdominal operation and its clinical significance].
Zhang WB; Jiang HP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):246-9. PubMed ID: 19246290
[TBL] [Abstract][Full Text] [Related]
19. [Gut barrier in the critically ill patient: facts and trends].
Velasco N
Rev Med Chil; 2006 Aug; 134(8):1033-9. PubMed ID: 17130993
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide synthase inhibition on glutamine action in a bacterial translocation model.
Santos RG; Quirino IE; Viana ML; Generoso SV; Nicoli JR; Martins FS; Nogueira-Machado JA; Arantes RM; Correia MI; Cardoso VN
Br J Nutr; 2014 Jan; 111(1):93-100. PubMed ID: 23773381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
